Concern over bird flu virus resistance
Source: Agencies |
00:55 UTC+8 May 29, 2013
|
Print Edition
Print Edition
A NEW bird flu strain that killed 37 people in China has proved resistant to Tamiflu for the first time, a development scientists said was "concerning."
The H7N9 virus was found to be resistant to Roche's widely used flu drug in three out of 14 patients who were studied by doctors from Shanghai and Hong Kong.
Tamiflu, which is given as a pill, belongs to a group of medicines known as neuraminidase inhibitors that currently offer the only known treatment option for bird flu. GlaxoSmithKline's inhaled medicine Relenza has the same mode of action.
In one patient, the gene mutation responsible for resistance appears to have arisen after infection took hold, probably as a result of treatment with Tamiflu, leading to concerns that medication may be the trigger for resistance to develop.
"The apparent ease with which antiviral resistance emerges in A/H7N9 viruses is concerning; it needs to be closely monitored and considered in future pandemic response plans," the researchers wrote in an article published online by The Lancet medical journal yesterday.
Earlier genetic studies had raised worries about drug resistance but this is the first time the problem has been documented in clinical cases.
For most of the 14 patients studied, Tamiflu successfully reduced the amount of virus found in throat swabs and helped speed clinical recovery. But it had no impact on the amount of virus found in swabs from three patients who became severely ill.
A spokeswoman for Swiss-based drugmaker Roche said rates of Tamiflu resistance remained low globally, but it took the issue of resistance "very seriously" and was collaborating with health authorities to monitor the situation.
The H7N9 virus has infected 131 people in Chinese mainland since February.
Experts from the UN Food and Agriculture Organization said last week the outbreak had caused some US$6.5 billion in losses to the Chinese economy.
Scientific studies of the virus have established it is being transmitted from birds - probably mostly chickens - to people. But experts have yet to identify the source of the circulating virus that is leading to chickens contracting it.
The H7N9 virus was found to be resistant to Roche's widely used flu drug in three out of 14 patients who were studied by doctors from Shanghai and Hong Kong.
Tamiflu, which is given as a pill, belongs to a group of medicines known as neuraminidase inhibitors that currently offer the only known treatment option for bird flu. GlaxoSmithKline's inhaled medicine Relenza has the same mode of action.
In one patient, the gene mutation responsible for resistance appears to have arisen after infection took hold, probably as a result of treatment with Tamiflu, leading to concerns that medication may be the trigger for resistance to develop.
"The apparent ease with which antiviral resistance emerges in A/H7N9 viruses is concerning; it needs to be closely monitored and considered in future pandemic response plans," the researchers wrote in an article published online by The Lancet medical journal yesterday.
Earlier genetic studies had raised worries about drug resistance but this is the first time the problem has been documented in clinical cases.
For most of the 14 patients studied, Tamiflu successfully reduced the amount of virus found in throat swabs and helped speed clinical recovery. But it had no impact on the amount of virus found in swabs from three patients who became severely ill.
A spokeswoman for Swiss-based drugmaker Roche said rates of Tamiflu resistance remained low globally, but it took the issue of resistance "very seriously" and was collaborating with health authorities to monitor the situation.
The H7N9 virus has infected 131 people in Chinese mainland since February.
Experts from the UN Food and Agriculture Organization said last week the outbreak had caused some US$6.5 billion in losses to the Chinese economy.
Scientific studies of the virus have established it is being transmitted from birds - probably mostly chickens - to people. But experts have yet to identify the source of the circulating virus that is leading to chickens contracting it.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
